Fig. 3: The XPRIZE/OpenCovidScreen competition. | Nature Biotechnology

Fig. 3: The XPRIZE/OpenCovidScreen competition.

From: The COVID-19 XPRIZE and the need for scalable, fast, and widespread testing

Fig. 3

The OpenCovidScreen competition is intended to identify fast, scalable, and cheap SAR-CoV-2 virology tests through a series of phases, starting with submitting test and method information (top), a proficiency test including blinded samples, and a clinical validation phase (middle). The top competitors identified on the basis of their methods, results and scalability will then be chosen for deployment to enable widespread usage of their tests (bottom).

Back to article page